BEATRICE CORONA: Open Payments
NPI 1407124282 · EDINBURG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$146 in 7 payments from 5 companies in 2025. Trend: 2023 $165 · 2024 $154 · 2025 $146
Food & beverage: $146
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Alkermes, Inc. | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 |
Products named: REXULTI, ARISTADA, FANAPT, INGREZZA, COBENFY.
Industry payments across TX — which companies pay providers there.
